 |
市場調查報告書
商品編碼
1672700
小分子藥物研發市場：依治療領域、流程、最終用戶和地區分類Small Molecule Drug Discovery Market, By Therapeutic Area, By Process, By End User, By Geography |
||||||
2025 年全球小分子藥物研發市場規模預估為 610.4 億美元，預計到 2032 年將達到 1,102.3 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 8.8%。
| 報告範圍 | 報告詳細資訊 | ||
|---|---|---|---|
| 基準年 | [2024年] | 2025 年市場規模 | 610.4億美元 |
| 效能資料 | 2020-2024 | 預測期 | 2025-2032 |
| 預測期：2025 年至 2032 年複合年成長率 | 8.80％ | 2032 年金額預測 | 1102.3億美元 |
小分子藥物具有大分子藥物所不具備的優勢，例如生物有效性度高、組織滲透性高。它也可以透過多種途徑給藥，包括口服和靜脈注射。製藥和生物技術公司對研發活動的投資不斷增加以及對學名藥的需求不斷成長，推動了市場的成長。然而，臨床試驗期間的高退出率可能會阻礙市場的成長。此外，一些新興企業正在利用人工智慧和機器學習等技術來加強藥物發現過程並降低失敗率。
市場動態
全球小分子藥物研發市場的成長得益於醫藥研發支出的增加、學名藥需求的不斷成長以及合約研究和製造服務行業的成長。然而，候選藥物的高臨床失敗率和嚴格的法規可能會阻礙市場的成長。人工智慧和機器學習在藥物開發領域的開創性發展正在為市場參與企業創造新的機會。製藥公司擴大採用此類技術來加快發現過程並最佳化分子設計。這可以減少離職率。目前，北美由於大型公司的存在和高額的醫療保健支出而佔據市場主導地位。預計亞太地區將在不久的將來成為成長最快的市場。
研究的主要特點
本報告對全球小分子藥物研發市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%）。
它強調了各個領域的潛在商機並解釋了該市場的有吸引力的投資提案矩陣。
它還提供了關於市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的主要考察。
全球小分子藥物研發市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數進行的分析。
主要企業包括輝瑞、百時美施貴寶、默克、安捷倫科技、Astra Zeneca、勃林格殷格翰和 Charles River Laboratories。
本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球小分子藥物發現市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員將透過全球小分子藥物發現市場分析中使用的各種策略矩陣來做出決策。
目錄
第1章 調查目的與前提條件
- 研究目標
- 先決條件
- 簡稱
第2章 市場展望
- 報告描述
- 市場定義和範圍
- 執行摘要
第3章市場動態、法規與趨勢分析
- 市場動態
- 影響分析
- 監管情景
- 產品發布/核准
- PEST分析
- 波特分析
- 併購情景
4. 2020 年至 2032 年按治療領域分類的全球小分子藥物發現市場（美元）
- 介紹
- 腫瘤學
- 中樞神經系統
- 心血管
- 呼吸系統
- 代謝紊亂
- 胃腸道
- 其他
5. 2020 年至 2032 年全球小分子藥物發現市場（按流程分類）（美元）
- 介紹
- 目標識別/檢驗
- 命中生成和選擇
- 線索識別
- 先導藥物最適化
6. 2020 年至 2032 年全球小分子藥物發現市場（以最終用戶分類）（美元）
- 介紹
- 製藥公司
- 生技公司
- 合約研究組織 (CRO)
- 學術研究所
- 其他
7. 2020 年至 2032 年全球小分子藥物發現市場（按地區分類）（美元）
- 介紹
- 北美洲
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
- 非洲
第8章 競爭格局
- Pfizer Inc.
- Merck & Co., Inc.
- Novartis AG
- Johnson & Johnson
- AstraZeneca PLC
- GlaxoSmithKline plc
- Bristol Myers Squibb
- Eli Lilly and Company
- Gilead Sciences, Inc.
- Teva Pharmaceuticals
- Boehringer Ingelheim GmbH
- Thermo Fisher Scientific Inc.
- Charles River Laboratories
- Labcorp Drug Development
- Agilent Technologies Inc.
- ICON Plc
- Eurofins Discovery
- Immunocure Inc.
- Acacia Pharma Group
- 4SC AG
第9章分析師建議
- 興衰
- 一致的機會地圖
第10章參考文獻與調查方法
- 參考
- 調查方法
- 關於出版商
Global Small Molecule Drug Discovery Market is estimated to be valued at USD 61.04 Bn in 2025 and is expected to reach USD 110.23 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 61.04 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 8.80% | 2032 Value Projection: | USD 110.23 Bn |
Small molecule drugs have advantages over large molecule drugs such as higher oral bioavailability and better tissue penetration. These can be administered via various routes including oral, intravenous and others. Growing investment in R&D activities by pharmaceutical and biotech companies coupled with rising demand for generics can drive the market growth. However, high attrition rates during clinical trials can hamper the market growth. Several startups also leverage technologies such as artificial intelligence and machine learning to enhance the drug discovery process and reduce failure rates.
Market Dynamics:
Global small molecule drug discovery market growth is driven by rising pharmaceutical R&D spending, increasing demand for generic drugs, and growth of contract research and manufacturing services industries. However, high clinical failure rates of drug candidates and stringent regulations can hamper the market growth. Growing application of AI and machine learning in drug development offers new opportunities for the market players. Pharma companies are increasingly adopting such technologies to speed up the discovery process and optimize molecular designs. This can lower attrition rates. North America dominates the market currently, owing to presence of major players and high healthcare expenditure. Asia Pacific is anticipated to emerge as the fastest growing market in the near future.
Key features of the study:
This report provides in-depth analysis of the global small molecule drug discovery market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global small molecule drug discovery market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer, Bristol-Myers Squibb Company, Merck, Agilent Technologies, AstraZeneca, Boehringer Ingelheim, Charles River Laboratories
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global small molecule drug discovery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global small molecule drug discovery market
Detailed Segmentation-
- Therapeutic Area Insights (Revenue, USD, 2020 - 2032)
- Oncology
- Central Nervous System
- Cardiovascular
- Respiratory
- Metabolic Disorders
- Gastrointestinal
- Others
- Process Insights (Revenue, USD, 2020 - 2032)
- Target ID/Validation
- Hit Generation and Selection
- Lead Identification
- Lead Optimization
- End User Insights (Revenue, USD, 2020 - 2032)
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organizations (CROs)
- Academic and Research Institutes
- Others
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Pfizer Inc.
- Merck & Co., Inc.
- Novartis AG
- Johnson & Johnson
- AstraZeneca PLC
- GlaxoSmithKline plc
- Bristol Myers Squibb
- Eli Lilly and Company
- Gilead Sciences, Inc.
- Teva Pharmaceuticals
- Boehringer Ingelheim GmbH
- Thermo Fisher Scientific Inc.
- Charles River Laboratories
- Labcorp Drug Development
- Agilent Technologies Inc.
- ICON Plc
- Eurofins Discovery
- Immunocure Inc.
- Acacia Pharma Group
- 4SC AG
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Small Molecule Drug Discovery Market, By Therapeutic Area
- Global Small Molecule Drug Discovery Market, By Process
- Global Small Molecule Drug Discovery Market, By End User
- Global Small Molecule Drug Discovery Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Small Molecule Drug Discovery Market, By Therapeutic Area, 2020-2032, (USD)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
- Central Nervous System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
- Cardiovascular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
- Respiratory
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
- Metabolic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
- Gastrointestinal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
5. Global Small Molecule Drug Discovery Market, By Process, 2020-2032, (USD)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Target ID/Validation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
- Hit Generation and Selection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
- Lead Identification
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
- Lead Optimization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
6. Global Small Molecule Drug Discovery Market, By End User, 2020-2032, (USD)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
- Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
7. Global Small Molecule Drug Discovery Market, By Region, 2020 - 2032, (USD)
- Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, (USD)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, (USD)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, (USD)
- Market Size and Forecast, By Process, 2020 - 2032, (USD)
- Market Size and Forecast, By End User, 2020 - 2032, (USD)
- Market Size and Forecast, By Country, 2020 - 2032, (USD)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, (USD)
- Market Size and Forecast, By Process, 2020 - 2032, (USD)
- Market Size and Forecast, By End User, 2020 - 2032, (USD)
- Market Size and Forecast, By Country, 2020 - 2032, (USD)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, (USD)
- Market Size and Forecast, By Process, 2020 - 2032, (USD)
- Market Size and Forecast, By End User, 2020 - 2032, (USD)
- Market Size and Forecast, By Country, 2020 - 2032, (USD)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, (USD)
- Market Size and Forecast, By Process, 2020 - 2032, (USD)
- Market Size and Forecast, By End User, 2020 - 2032, (USD)
- Market Size and Forecast, By Country, 2020 - 2032, (USD)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, (USD)
- Market Size and Forecast, By Process, 2020 - 2032, (USD)
- Market Size and Forecast, By End User, 2020 - 2032, (USD)
- Market Size and Forecast, By Country, 2020 - 2032, (USD)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, (USD)
- Market Size and Forecast, By Process, 2020 - 2032, (USD)
- Market Size and Forecast, By End User, 2020 - 2032, (USD)
- Market Size and Forecast, By Country/Sub-region, 2020 - 2032, (USD)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AstraZeneca PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bristol Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Gilead Sciences, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boehringer Ingelheim GmbH
- Thermo Fisher Scientific Inc.
- Charles River Laboratories
- Labcorp Drug Development
- Agilent Technologies Inc.
- ICON Plc
- Eurofins Discovery
- Immunocure Inc.
- Acacia Pharma Group
- 4SC AG
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
